Tenatoprazole

File:Tenatoprazole.svg

Tenatoprazole.svg

Proton pump inhibitor

Tenatoprazole
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Tenatoprazole is a proton pump inhibitor (PPI) used in the treatment of gastroesophageal reflux disease (GERD) and other conditions involving excessive stomach acid production. It is similar to other PPIs such as omeprazole, lansoprazole, and pantoprazole, but has a longer duration of action.

Mechanism of Action

Tenatoprazole works by irreversibly inhibiting the H+/K+ ATPase enzyme system (also known as the proton pump) in the parietal cells of the stomach. This inhibition prevents the final step in the production of gastric acid, thereby reducing acid secretion.

Pharmacokinetics

Tenatoprazole has a longer half-life compared to other PPIs, which allows for prolonged acid suppression. This can be beneficial in managing conditions that require sustained acid control.

Clinical Uses

Tenatoprazole is primarily used to treat:

• Gastroesophageal reflux disease (GERD)
• Peptic ulcer disease
• Zollinger-Ellison syndrome
• Erosive esophagitis

Side Effects

Common side effects of tenatoprazole include:

• Headache
• Nausea
• Diarrhea
• Abdominal pain

Serious but rare side effects may include:

• Hypomagnesemia
• Clostridium difficile infection
• Osteoporosis-related fractures

Comparison with Other PPIs

Tenatoprazole's longer duration of action distinguishes it from other PPIs, potentially offering better control of nocturnal acid breakthrough. However, its clinical advantages over other PPIs are still under investigation.

See Also

• Proton pump inhibitor
• Gastroesophageal reflux disease
• Peptic ulcer disease
• Zollinger-Ellison syndrome